Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
23.20
-4.10 (-15.02%)
At close: Jan 12, 2026, 4:00 PM EST
23.34
+0.14 (0.60%)
After-hours: Jan 12, 2026, 7:57 PM EST
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.94 billion as of January 12, 2026. Its market cap has decreased by -29.18% in one year.
Market Cap
2.94B
Enterprise Value
2.93B
1-Year Change
-29.18%
Ranking
Category
Stock Price
$23.20
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $2.94B, an increase of 324.74%. That is a compound annual growth rate of 19.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 2.94B | -7.64% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
| Nov 9, 2017 | 691.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |